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Disruptive Innovation is a complex concept introduced in 1995 by Harvard Business School 
professor Clayton M. Christensen, and describes a situation when simpler technology unseats 
the dominant one in the industry. However, currently it became a very popular “buzzword” 
and many innovations are called that way without a throughout analysis. eHealth, an ICT-
based innovation within the healthcare delivery is commonly called disruptive in many 
publications such as: professional articles and books. However, there has never been done a 
detailed analysis to support this hypothesis. This work aims to analyze if the label of 
disruptiveness is suitable for this specific technology. The main characteristics of the concept 
were listed and subsequently tested whether they apply to eHealth - innovation within very 
peculiar healthcare delivery industry. This analysis indicated that eHealth, although may 
become disruptive, does not fit into traditional disruptive theory framework proposed in 1995.  
 














2. Research objective 
E-health, ICT innovation within healthcare delivery has already led to significant advances in 
a patient’s provision and a doctor’s efficiency worldwide (Christensen, Bohmer & Kenagy, 
2000). This technology is commonly called as disruptive, by consulting companies Deloitte 
and McKinsey (McKinsey & Company, 2014) (Deloitte, 2014), Christensen’s Institute 
(Vijayaraghavan, 2011),  in the professional articles (Yellowlees et al, 2011), books (Gurtner 
& Soyez, 2014) and commonly on the Google search websites, among others. That implies 
that it gives or has potential radically change the the market rules for both companies and 
customers (Gilbert, 2003). The theoretical concept itself is complex, but the term became 
lately a very popular “buzzword” (Yglesias, 2013) and therefore many innovations are 
labelled as disruptive without a throughout analysis (European Comission, 2015). Although 
eHealth is widely quoted as disruptive innovation there is no study that examines if it is in line 
with theoretical model and fulfills all the necessary conditions. These attributes were first 
described by Christensen in the publication “the Innovators Dilemma” based on the disk-drive 
industry and were verified on steel and retailing industries, among others (Christensen & 
Utterback, 1997).  Therefore, it is unclear and need to be tested whether theory characteristics 
will apply to highly regulated healthcare, not regular profit-led market. This work starts by 
listing the most important attributes of the Christensen’s disruptive innovation model and then 
use a qualitative analysis procedure to assess if they apply to eHealth, the innovation within 
healthcare. There will be no formal statistical hypothesis testing performed, but its steps will 
be used as a framework for qualitative research. The analysis will be conducted using 
professional articles and case studies searched in the PubMed, Web of Science databases, 




3. Innovation in Healthcare – Literature Review 
Christensen’s model of a disruptive innovation  
There are numerous articles that tackle the topic of innovation within a medical industry and 
the nature of innovation has already been widely described. Although high importance of 
innovation in the development of economic entities, there has not been worked out one 
specific definition of this notion. Meanings quoted in the literature differ when it comes to the 
scope and subject of innovation. (Elspeth McFadzean, 2005). According to the definition 
widely used in the healthcare-related literature, innovation is “an idea, practice, or object that 
is perceived as new by an individual or other unit of adoption if an idea seems new to the 
individual” (Rogers, 1962).  
In 1995 Clayton M. Christensen introduced a model of innovation, that can be described 
either as sustaining or disruptive. Sustaining innovation is characterized as a modification that 
advances the product within the traditional performance frameworks. On the other hand, 
“Disruptive innovation is a powerful means of broadening and developing new markets and 
providing new functionality, which, may disrupt existing market linkages” (Christensen & 
Utterback, 1997). It is a theoretical term to explain the situation when new company serves 
completely new customers or targets least profitable customers with new products. This new 
entrant is usually capable of challenging industry giants and disordering old systems with a 
smaller cost. (Kopalle, 2006) Specifically, incumbents, market leaders, with a time start to 
ignore the least-profitable customers and put existing product improvements in the center of 
attention in order to appeal to their leading, most profitable customers. Thus, they often miss 
the business opportunity coming from not yet existing markets or from least profitable ones. 
The entrants that eventually turn out to be disruptive start by targeting the segments that are 
overlooked by incumbents in the process of providing products of significantly lower 
performance level and lower cost (Christensen & Utterback, 1997). Nevertheless, with a time, 
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the entrants improve and move to the mainstream market while retaining and improving the 
innovation that accelerated their early success. At the moment when mainstream customers 
begin to adopt the entrants’ products or services in volume, the disruption is arousing.  
Disruptive innovation within healthcare 
There are disruptive innovations that have already transformed healthcare, and resulted in 
increased quality, considerably greater convenience, consumer satisfaction while at the same 
time have decreased overall costs. Example cited by Christensen is angioplasty. Before this 
innovation, patients who had disease of coronary artery were treated with a bypass surgery. It 
was a very complex operation requiring multiple specialists, technologically sophisticated 
equipment and weeks of recovery (Krans i Watson, 2015). Angioplasty, as an innovation, 
supports most of the Christensen’s theoretical model characteristics. For example, it is so 
simple, that it can be performed in cardiac-care centers which significantly decrease the costs. 
It is also much more convenient way of treatment as it causes less pain and disabilities for a 
patient (Berlin, 2006). Moreover, the agents of incumbents leading customers – surgeons were 
sceptic about the procedure because of its limited performance (Sensmeier, 2012). Indeed, it 
was much less effective then bypasses and therefore was used only in the simplest cases. 
(Zimlichman & Jeffrey Levin-Scherz, 2013). However, sustaining technological innovations 
together with gained experience and skills, allowed angioplasty to replace complex bypass 
surgery in many cases. Additionally, as the specialists focus on the sickest of patients, less-
skilled medical stuff is allowed to perform treatment of coronary artery diseases. That serves 
efficiency to the specialists work-time. All of the mentioned characteristics imply that 





Table 1 Description of disruptive innovation main characteristics, relevant hypothesis and methods of evaluation 
4.  Methodology 
The work aims to evaluate weather eHealth adhere to already defined disruptive innovation 
characteristics. The research will take a form of a detailed case study of the eHealth industry. 
The following attributes of the theory will be enumerated and consequently assessed based on 
published evidence:  
 
The formal statistical testing of hypotheses will not be performed, but its steps will be used as 
a framework to qualitatively answer the research question. To assess the validity of 
hypotheses the following steps will be taken:  
1. obtaining the hypothesis from a general literature,  
2. review of articles that assess the use of eHealth,  
3. subtraction of articles relevant to the topic,  
4. defining weather the enumerated features will support the null hypothesis or not.  
The articles used to evaluate hypotheses 1-3 were searched within the Web of Science 
(Thomson Reuters) and PubMed databases. The criterion of the selection was the quality of 
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indexed journals. The analyzed publications include: articles, proceeding papers and reviews. 
The example search queries were “eHealth outcomes” or “eHealth cost” and the results were 
filtered according to their relevance. Findings of the hypotheses 4 and 5 are based on high-
quality consulting companies’ reports, statistical resources, Christensen’s Institute articles and 
business journal articles. Every hypothesis consists of relevant Christensen’s theory 
description and its healthcare industry specific deviations, description of the most interesting 
findings and conclusions. This work will cover seven products and services within eHealth 
industry. These 7 particular technologies were chosen with regard to their overall market 
share in the eHealth industry, as well as the quality of available literature. These are as 
follows: 
1) Electronic Health Record (EHR): health-related information of a patient can be created, 
conferred, and managed in form of an electronic record by doctors or medical staff  
4) Computerized Physician Order Entry (CPOE): systems that allow doctors to enter all 
the patient’s treatment instructions, which are also available for other departments (like 
pharmacies, radiology etc.) or medical staff 
3) Telemedicine: systems that use audio/video virtual communication to deliver health 
services at a distance 
2) Self-monitoring: data-based continuous patient tracking and evaluation systems  
3) mHealth: known also as mobile health. These are all mobile-based and mobile-enhanced 
innovations that deliver care; it includes smartphone applications, SMS services, smartphone 
connected wearable devices and other 
5) Clinical Decision Support System: describes a system created to enhance clinical 
decision-making. Different characteristics of a patient are coordinated towards a base of 
automated knowledge, in order for software algorithms to create individual recommendations 
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6) Research Data Collection System: a system used to collect, store, manage or report on 
research data from different locations 
5. Hypothesis 1: Does eHealth have inferior performance than paper-based healthcare 
delivery?  
Christensen’s theory and its healthcare specific application  
A core concept of the disruptive innovation is that incumbent firms provide many product 
improvements that excel market needs and its financial capabilities. When the oversupply of 
performance occurs, it provides business opportunity for companies that will deliver lower 
cost and lower quality products. That way they will satisfy the least demanding customers. 
Also, usually at the moment when innovators enter the market, products seem to be used in 
different, unexpected ways. In the end, through successive sustaining innovation they are able 
to gain incumbents leading customers and fulfill market demands. Nevertheless, healthcare is 
a highly regulated industry and there are many restrictions regarding launched products. Thus, 
the disruption process may deviate from established model for other industries. This 
hypothesis is supported by studies that analyze disruption within markets of tissue valves 
(Berlin, 2006) and automatic external defibrillators (Lim, Hang i Neo, 2008). Authors indicate 
that the product needs to go through complex process of pre-market approval before the 
market entry.  It must display certain increased performance features and therefore it cannot 
represent inferior performance. Also, a development process needs to be specified upfront 
which restrain customers from experimenting with its use. Thus, it is hypothesized that 
disruptive innovation within healthcare industry will not demonstrate inferior performance.  
The testing of hypothesis that eHealth initially represents inferior performance than paper-
based healthcare delivery was conducted in two dimensions: patient health outcomes (74 
studies) and clinical processes efficiency (74 studies). The detailed analysis together with the 
full list of used articles can be found in the Appendixes 3 and 4.  
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Findings on eHealth performance from the patients’ health outcomes perspective 
Table 2 Summary of findings on patients' outcomes 
A majority of studies regarding patient’s health outcomes prove, as opposite to the theory 
proposed by Christensen, that eHealth technologies represent superior performance to the 
paper-based healthcare delivery (58%). Also, 72 out of 74 reviewed studies did not indicate 
inferior performance and 2 showed decrease in health outcomes. The most citied effect on 
patient’s health is the increase in QALYs (quality-adjusted life year) as an indirect effect of 
increased health knowledge and access to healthcare, more accurate diagnosis and increased 
adherence to medical treatment. Studies also indicated that eHealth can reduce morbidity or 
complications after treatment. There are also studies that prove the effectiveness of eHealth 
technologies with the relevance to elderly, such as decreased number of falls or pressure 
ulcers (Dowding DW1, 2012). The implementation of a post-acute CDSS relatively reduced 
readmissions by 26% in one study (Bowles K, 2014). Another one that used computerized 
identification of patients with high-risk showed a decrease from 0.36% to 0.17% in end point 
of deep venous thrombosis (Robert C. Amland, 2014). Next example, presented a 0.5–
percentage point absoluteodecrease in the postoperative infections (Andersen, 2008). 
Moreover, other studies examined that eHealth implementation has effect on the rate of 
complications related to treatment. The EHRs systems were able to decrease adverse drug 
event rates from 7.6% to 2.2% (Balthasar L. Hug, 2010). Despite a lot of evidences for the 
efficiency of telemonitoring and improvement care for elderly, there are also studies that do 
not confirm these benefits. For example, telemonitoring caused a fourfold increase in a death 
risk within patients over 60. This research might suggest that telemonitoring used by the 
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leading customer group - chronic-care elderly patients, may cause more harm than good. 
(Takahashi, et al., 2012).  
Findings on eHealth outcomes from the perspective of medical process efficiency 
A majority of studies regarding clinical process efficiency indicate that eHealth represents 
superior performance to the paper-based healthcare delivery (55%). Also, 67 out of 74 
reviewed studies did not indicate inferior performance and only 7 showed a decrease in 
efficiency. The most citied effect of eHealth implementation is a decreased time of a 
treatment which is a result of a growing adherence to protocols and guidelines, more accurate 
diagnosis, availability of continuous remote patient monitoring and process simplification that 
allows less skilled staff and patients themselves to fulfill some of the doctor’s routines. 
Improvements in healthcare delivery processes range from 3 to 66 percentage points within 
the reviewed literature. 
The effects of eHealth on clinical procedure time are mixed. For example, two studies showed 
growths in doctor’s time associated with a computer use. Using IT systems increased doctors 
time of documentation by 17.5% (Poissant, Pereira, Tamblyn, & Kawasumi, 2005). Other 
studies underlined positive impact of eHealth on laboratory testing time or completion of 
advanced directives (Dexter, et al., 1998). Using of tablets and central systems has saved 
nurses 23.5% of their time spent on documents completion. (Poissant, Pereira, Tamblyn, & 
Kawasumi, 2005) In contrast, other study examining the effect of CPOE desplayed no 
benefits on a nurse documentation time (Kilgore, 2010). Also Deloitte reports that the average 
results of eHealth solutions for nurses present as follows: minus 60% of paperwork time, plus 
29% of patient face-to-face time and two extra patients seen per day. A telehealth hub across 
Table 3 Summary of findings on patients' outcomes 
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210 care homes caused: minus 35% of hospital admissions and minus 59% in hospital bed 
days (Deloitte, 2014). Both doctors and nurses perceived EHRs information quality as 
improved, especially in the areas of: accuracy (8-studies), accesso(5-studies), 
comprehensiveness (3-studies), and access to up-to-date patients’ data (7 studies). reductions 
in other areas were as follows: decreased medication turnaround time by 64%, radiology 
procedure time by 43%, laboratory reporting time by 25% (Mekhjian, et al., 2002). The 
system also influenced medication errors. Before implementation transcription errors 
accounted for 13% of orders, after - errors were eliminated. (Cordero, Kuehn, Kumar, & 
Mekhjian, 2012). The review has found out that CDSS systems have positively impacted 
healthcare professionals’ performance in 57% of cases. The main improvement factors were 
ordering of drugs systems and preventive reminders. 
Conclusions 
The research indicated that eHealth most of the time enhances performance in both areas: 
when it comes to patient health outcomes and clinical process efficiency. However, the study 
of older articles illustrated that eHealth might be very close to traditional disperse of 
disruptive innovation. Articles that studied technologies before their implementation showed 
considerable problems with performance such as a lack of ability to process large amounts of 
data (McDonald, 1997) or poor quality of images/communication (Institute of Medicine, 
1996).  However, there might have occured so called “publication bias”. That means that most 
of the articles which are published confirm the technology efficency, wheareas articles that 
fail to confirm null hypothesis do not see the day light (Hilten, 2015). Such bias, if exists, 
might be in favor to confirm the hypothesis. However, based on the analyzed articles, 
conclusion is clear that eHealth often does not initially represent lower performance. 
However, as mentioned in the theoretical part, due to restrictions in law regarding medical 
equipment, the performance cannot often be initially inferior. As a result, hypothesis that 
12 
 
eHealth will initially have inferior performance than paper-based healthcare delivery, can be 
rejected. 
6. Hypothesis 2: Do healthcare leading customers not want to use eHealth?  
Christensen’s theory and its healthcare specific application  
Another key concept of Christensen’s theory is that initially profitable customers of the 
incumbent firms do not want or cannot use the new, to-be-disruptive technology. Incumbent 
companies will mostly evaluate market potential by rigorous research of the most profitable 
customers’ needs. Therefore, it is highly probable that incumbents will underestimate the 
possible impactoof a disruptiveoinnovation andomake theoseeminglyorational choice to reject 
the investment in the disruptiveotechnology (Berlin, 2006). The role of leading customers in 
Christensen’s theory is principally relevant in the context of medical industry.  
It is a big challenge to define the term “leading customer” for the eHealth innovations. If the 
patients were ranked by how much they cost to be treated annually, it turns out that 1% of 
population accounts for almost 23% of expenditure, and the top 10% relates to 70% of 
spending (Shanahan, 2014). Moreover, it is estimated that this costliest group of customers in 
healthcare are chronic-care citizens over 65 years old (Nam, 2015). For that reason, this group 
stands for the leading customers of companies which focus on profits and growth - 
incumbents. Also, multiple researches demonstrated a highly significant role of the doctor 
contribution in the development of disruptive technologies (Lettl, Herstatt, & Gemuenden, 
2006). Therefore, for the purpose of this work, leading customers will be defined as end-users 
of eHealth technology - patients and doctors. The patients will be limited to the costliest 




 51 articles (Appendix 5) were reviewed in order to test the hypothesis that eHealth is initially 
rejected by leading customers. Over 75% of them indicated that both doctors and patients are 
supportive and enthusiastic towards the technology. Most of the studies used the Technology 
Acceptance Model that measures “perceived ease of use” defined as “the degree to which an 
individual believes that using a specific system will be free of effort” and “perceived 
usefulness” of a solution which is “the degree to which an individual believes that using a 
system would improve his or her work performance” (Davis, Bagozzi, & Warshaw, 1989)  
Findings on leading customers’ perception of eHealth comparing to traditional healthcare 
delivery 
Most of the studies that negatively valued eHealth came from the doctors. The aspects of 
eHealth that were positively evaluated were “ease of use” and “functioning”. The improved 
care and the increased collaboration are named by them as the potential benefits of technology 
in healthcare (73% and 75% of doctors respectively) (Deloitte, 2014). In one survey, 9 out of 
10 doctors admit that they are interested in eHealth technology and it has clinical value.  
However, the security and privacy issues seem to be a constraint for eHealth - over 43% of 
doctors pointed it out as a barrier for commercialization. (Sivasubramaniam, 2005). The most 
important problems citied were ‘lack of training’, ‘high cost’, and ‘workload increase’ 
(Brown SA, 2002). Moreover, 3 out of 4 doctors say that EHRs do not save time and increase 
costs (Vijayaraghavan, 2011). In one study 68% of them admit that technology does not 
enhance their productivity, 58% say it does not differentiate the treatment among patients and 
48% that it does not support care coordination (Deloitte, 2014). The most commonly cited 
reasons for such a low adoption willingness are that systems are not well optimized yet, 
Table 4 Summary of findings on end-user perception 
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cannot process such big volumes of patient’s data and doctors fear of useless statistics 
(Bresnick, 2015). In another survey by eClicalWorks it turned out that over 93% of specialists 
would be more willing to embrace eHealth if the integration with EHR would be better. 
(Bresnick, 2013). However, there are opinions that doctors resist to give more power to 
patients which can result in worse patient control (Topol, 2015). Additionally, doctors are not 
sure if monitoring would be a benefit of eHealth solutions and only 38% admitted that there is 
a potential in this field. That highly contrasts to 60% of patients who want to use eHealth to 
track their medical and wellness records (Mobiquity, 2013). 
A study conducted by Bujanowska-Fedak from 2014 indicated that around 41% of the elderly 
patients over 65 years old had an advantageous attitude towards eHealth and were enthusiastic 
to try it once the opportunity to do so is offered (Bujnowska-Fedak & Pirogowicz, 2014). In a 
study conducted by Agrell most of the seniors had a neutral (60%) or a positive (33%) attitude 
regarding technology before a use of remote eHealth services. After they used the technology, 
vast majority of them were very satisfied (67%) or rather satisfied (33%) with eHealth 
services (Agrell, Dahlberg, & Jerant, 2000). Another characteristic of elderly patients is a 
strong willingness to have a direct contact with the specialist. 61% of elderly report strong 
preference for the face-to-face contact and cite it as the main cause of not approaching the 
doctor via the Internet (Bujnowska-Fedak & Mastalerz-Migas, 2015). Seniors often show high 
resistance to new technologies which can be caused by age-related decrease of motor and 
cognitive functions (Campbell, 2015). Finances among elderly are the next barrier. Seniors, 
usually those who are needy, are afraid of the costs of buying a computer or other devices 
(Said, 2005). Most of them depend on a third party, typically company insurer or government 
to reimburse their healthcare and infrequently make out-of-pocket purchases (OECD, 2007). 
Their access to the Internet network and telecommunication can be also very limited (Internet 




The analysis of leading customer’s attitudes towards the use of eHealth and barriers to adapt it 
appear to provide conflicting results. In vast majority of studies, they point out problems that 
stop them from using eHealth innovations. Among them there are: high cost of technology, 
not enough optimized systems or personal preferences for face-to-face contacts. However, 
both elderly patients and doctors are supportive and enthusiastic about eHealth, and satisfied 
with its ease of use. Given this data, the hypothesis that leading customers do not want and 
cannot use disruptive innovation can be rejected. 
7. Hypothesis 3: Does eHealth represent lower cost opportunity than the paper-based 
healthcare delivery? 
Christensen’s theory and its healthcare specific application  
The model of disruptive innovation assumes that new technology will represent the lower cost 
and lower margin than incumbents business. The consequence of thisodynamic is that 
incumbents’ firms will be restrained from investing in a disruptive innovation. Again, 
healthcare industry specifics can cause deviations from the theory. When evaluating the value 
of products or services the cost is not a key driver when comparing to the clinical utility. 
Furthermore, there is always an in-between agent – the doctor, that occurs between the 
provider and the patient. The agent does not take under consideration the cost as the most 
important factor when making decisions, but the patients’ health outcomes. Hence, an ethical 
threat occurs, which depreciates the effect of a cost on the overall value proposition. 
Therefore, it is theorized that disruptive technology within healthcare delivery might turn out 
to be more profitable than incumbents technology. This can imply, so contrary to general rule 
of other industries, that there are motives for incumbents to commercialize and expand the 
disruptive technology (Berlin, 2006). Also measuring cost savings in healthcare is somehow 
problematic. Some of the reviewed studies did not measure cost savings in a direct way. As a 
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substitute, academics explained not monetized reductions in services into monetized 
approximations using the average cost of the service. For example, one study examined total 
costs per stay in hospital and found a decrease from $6964 to $6077 which was translated 
from 0.9-day reduction of admission (Tierney, Miller, Overhage i McDonald, 1993). 
Findings on cost savings and a cost-efficiency of eHealth compared to the paper-based 
healthcare delivery  
Table 5 Summary of findings on healthcare units costs 
Review of 39 articles (Appendix 6) implied that a transition to an electronic form of the 
healthcare delivery is likely to cause various financial benefits (21 out of 39 studies). For 
example, eHealth is believed to decrease healthcare costs connected to preventable diseases, 
as these are the problems eHealth is addressing. This accounts for around 70% of total 
expenditures (Heffler, Smith, Keehan i Borger, 2005). The savings are proved to come from 
better drug management, improved radiology practice, reduced billing errors and better 
capture of changes. According to McKinsey & Company in almost every scenario eHealth 
and the data it generates will decrease the need for beds in hospitals and force the public 
hospitals to be more efficient. Hospitals will be under competitive pressure to implement the 
latest information technologies and its adoption will furtherly drive down already small 
margins (McKinsey & Company, 2014). McKinsey estimates that the implementation of 
technologies that support patients’ self-services and digital networks of communication can 
result in 7 to 11 percent of net economic benefits in total healthcare spending (McKinsey, 
2015). On the other hand, NHS England evaluates that ”eHealth can save 6.5 to 10.8 percent 
of total healthcare spending in the UK by 2020” (Josip, et al., 2008). According to a cost-
benefit analysis of EHR in primary care by Wang at el. the average net benefit from EHR 
implementation for a 5-year period amount to $86,000 for a provider (Wang, et al., 2003). In 
17 
 
the same study sensitivity analysis included the most optimistic and the most pessimistic 
scenario after EMR implementation and showed results in a range from $331 thousand net 
benefit to 2300$ net cost (Wang, et al., 2003). Studies regarding telemedicine were varying 
regarding the costs of technology. Variable cost savings compared to paper-based system 
were $2.500 to $3.000 PMPY and hospital profits increased from $1.000 to $4.000 PMPY 
(per member per year). Another study analyzed the cost effectiveness of implementing 
eHealth in panic disorder treatments. It computed results that range from $3,300 to $4.400 per 
DALY (disability-adjusted life year) comparing to traditional treatment (Mihalopoulos C, 
2005). Moreover, in a cost-benefit study of adapting a standardized patient management 
program resulted in an incremental ratio of 3.7 (Runge C, 2006). Two studies from UK tried 
to access the ROI of an eHealth-based health promotion program. They reported positive ROI 
of almost 2 dollars for each invested dollar (Mills PR, 2007). Another study reported ROI of 
2.15 of an eHealth-based rehabilitation program (Southard BH, 2003). Moreover, Bain 
consulting company estimates that implementing eHealth in the area of administration can 
create savings of 10% in costs PMPY which accounts for $200 (Bain & Company, 2012). In 
addition, eHealth is estimated to generate savings of $750 PMPY or around 7% by better 
management of high-cost patients (McCall, Cromwell, & Urato, 2010). However, 71% of 
doctors believe that the reduction of costs due to eHealth is inflated and its use will eventually 
cost more, not less than traditional medicine (Sivasubramaniam, 2005).  
Conclusions 
Again, in this case it cannot be assumed that the “publication bias” did not occur. It is 
confirmed that the major reason for “nonpublication” are the negative results that do not 
confirm the eficacy of a topic (Dickersin, Chan, Chalmersx, Sacks, & Jr, 1987). However, 
analysis of the chosen articles supported the hypothesis that eHealth represents lower costs 
than paper-based healthcare delivery. 39 studies regarding eHealth costs were analyzed and 
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21 of them (54%) indicated the lower cost opportunity. Therefore, the null hypothesis cannot 
be rejected.  
8. Hypothesis 4: 4a) Does eHealth take root in low-end markets? 4b) Does it create new 
markets? 
Christensen’s theory and its healthcare specific application  
In the concept from 1995, Christensen identifies two types of disruptions: low-end and new 
market disruptions. The low-end disruption occurs when the new product or service is able to 
do the same thing as incumbent technology but can be sold with a lower price or access level. 
Therefore, it will “allow access to a product or service previously accessible only to the rich 
or skilled, lowering quality” (European Comission, 2015). When it comes to heatlhcare, this is 
not a relevant feature in most of the European countries. However, the concept could apply to: 
developing countries, where the cost of travel and treatment are significant barriers to receive 
healthcare, and the U.S., where the income is the most important aspect to access the 
healthcare (European Comission, 2015). People who were excluded from the healthcare 
market after disruption will be able to access it. The second type of disruption is a new market 
disruption. In opposite to the low-end one, it will not gain the least-profitable consumers, but 
will address the non-consumers in the category. The consumers who did not want, did not 
need or could not use the incumbent’s products will use the new ones. Healthcare delivery 
might experience new ways of undertaking things or fulfilling people’s needs and more 
efficiency within healthcare units. In this case, the new market created by eHealth might be a 
better way of delivering illness prevention. The nonconsumers are people who do not need 
healthcare yet, but because of the risk factors and lack of knowledge are prone to become the 





 eHealth new market disruption  
The modern lifestyle risk factors such as smoking, physical inactivity, alcohol consumption, 
obesity and poor nutrition are among of the main factors causing death and chronic diseases 
worldwide (Lopez, Mathers, M, Jamison, & Murray, 2006). Chronic diseases such as 
diabetes, cancer, heart diseases are the leading mortality causes in the world and are 
responsible for over 60% of all deaths (WHO, 2016). In the U.S. only, they account for $1.3 
trillion spending (DeVol R, 2007). These diseases are preventable in many cases, however the 
patients before getting sick represent “nonconsumers” of healthcare. The current health 
system does not have interest nor the time to raise its competitiveness against new entities 
which offer new value proposition to this low-cost (future high-cost) generations 
(Hueltenschmidt & Olsen, 2014). According to Christensen’s Institute, what this group really 
needs is the customized medical care that will enable them to stay low-contributors to the 
healthcare expenditures (Nam, 2015). eHealth, and especially mHealth among other 
innovations, target this group. This completely new market, promises the change in 
consumers’ behavior to prevent diseases. Despite recent development of guidelines for 
general doctors how to manage risk factors and prevent diseases the rates of actual practice 
remain low (Pham, Schrag, Hargraves, & Bach, 2005). For example, it is rarely met that 
doctors engage in counseling for obese people during their regular visits (Sonntag U, 2010). 
This gap between actual delivery rates and recommended care is also underlined by patient 
reports that indicate patients desire for more lifestyle advice. (Duaso MJ, 20002). According 
to Bain&Company 75% of consumers indicate that insurers and health systems should more 
focus on disease prevention than on healing, 67% claim that the information should be more 
Table 6 Summary of findings on low-end and new market disruption 
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scientific, personalized and integrated (Deloitte, 2014). This disparity prompts for alternative 
delivery of healthcare and collection of patient’s medical data. Within the last couple of years, 
many fitness, wellness and health-oriented products targeting healthy “nonconsumers” 
appeared on the market. The market of mHealth apps and devices is expected to reach US$ 24 
billion in 2017 (GSMA & PwC, 2014). In 2014 half of the smartphone users in America 
purchased at least one app that supports healthy-living, and about 19% of all adults is 
routinely using at least one app from this area (Agrawal, 2014). 18% of Americans claim to 
download the calorie counting app and 6% to use it regularly. Another popular type of 
healthy-living applications are exercising diaries and running maps (Agrawal, 2014). In the 
$3trillion US Healthcare sector, wellness and fitness market already stands for almost $270 
billion. Another key fact that supports eHealth development is that it remains the most 
feasible method of prevention management, although the self-reporting data accuracy might 
be affected by various factors (Connor Gorber S, 2009).   
eHealth low-end disruption in developing countries  
High income countries focus mainly on monitoring services and low income countries focus 
on electronic diagnosis services (GSMA & PwC, 2014). This is most probably caused by the 
overall healthcare situation. Low and middle income countries experience extremely low 
number of resources and doctors. According to WHO, recommended number of doctors is 22 
per 10.000 people in order to serve 80% of population (WHO, 2015). In Indonesia, India and 
China these numbers are 2, 6 and 14 respectively, in Africa the number drops to 2.5 (WHO, 
2016). When it comes to availability of beds in hospitals, it is 9 for 10.000 in Africa whereas 
in Europe it falls over 62 (The World Bank, 2016). Opposite to the access to healthcare, the 
access to mobile technology becomes almost ubiquitous globally. In developed countries the 
mobile penetration of market stands over 100%. These numbers for Africa, Asia Pacific and 
South America account for 86%, 99% and 120% accordingly (GSMA, 2016). Therefore, this 
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disparity accelerated the use of mobile devices to leverage access to healthcare in developing 
countries. The example can be Linda Jamii program in Kenya. The leading mobile operator 
together with the insurance company provided cheap and affordable option for uninsured 
Kenyans to access healthcare by paying with the use of a popular in Africa M-PESA program 
(Safaricom, 2016). This can be classified as a low-end disruption that allows the lowest-
income consumers to access the service that was previously impossible to reach. Moreover, in 
Africa over 75% of health deployments focuses on supporting remote access to patient, 
transmission and collection of patients’ data (PwC, 2015). Around 59% of patients in the 
emerging economies already use mobile health services. On the other hand, this number 
counts for only 35% among developed countries population (Siemens, 2015). 
Correspondingly, more specialists in developing markets are prone to use eHealth than the 
first-world doctors. Moreover, more payers will cover those costs. (Siemens, 2015). For 
example, the Mobile Doctors Network (MDNet), embraced the power of mobile technologies 
and created Ghana wide network of doctors (Chen, Sarah Baird, & Sinit Mehtsun, 2014). In 
Nigeria “We Care Solar” reduces maternal mortality by providing doctors provision using 
mobile technologies (We Care Solar, 2016). In addition, the Asian eHealth market is expected 
to undergo the biggest growth until 2020 (P&S Market Research, 2012). In China $9.8 billion 
was spent in 2012 to build public EMR system (Zhu, 2012). Moreover, this country launched 
five country-wide telemedicine pilots that enable the monitoring of patients from rural areas 
(Xinhua Finance, 2015). Chunyu, the biggest doctor consultation platform, receives 50 
thousand of daily inquiries and enables convenient healthcare to over 80 million of Chinese 
patients by 40 thousand doctors (Siyang, 2015). To solve the problem of access to healthcare 
in India, the “hub-and-spoke global delivery” model was introduced (KPMG, 2011). These 
“hubs” are linked to “spoke” facilities located in the rural areas, where patients are provided 
with the basic cheap care and diagnosis and are referred to larger hubs for more complicated 
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treatments. In the model doctors use telemedicine to remotely help people at a distance (Ross, 
2013). 
Conclusion 
Listed examples prove that eHealth not only creates new markets, but also targets the low-
end, least profitable customers. Among others, mHealth created industry of applications and 
wearables for fitness and wellness that is already worth US$1.49 trillion (PwC, 2015). 
Moreover, listed examples of initiatives in developing countries that target low income people 
living in rural areas prove the low-end disruption. Given this information, the hypotheses 
about low-end and new market disruption cannot be rejected. 
9. Hypothesis 5: Does eHealth create new market players?   
Christensen’s theory and its healthcare specific application  
The model of disruptive innovation assumes that incumbent firms will be restrained from 
investing in disruptive innovation. The reasons for that are: lower margin and unattractive 
market, which mixed represent relatively lower profit opportunities. Consequently, raising the 
concept of “resource dependence” (Davis & Cobb, 2009) it is doubted that incumbent 
organizational structure is able to develop disruptive innovations. The resources usually will 
be diverted away from the disruptive projects as they are connected to lower profits and 
companies will focus on sustaining innovation that in the initial research will promise higher 
profits. In consequence disruptive innovation should be commercialized by an independent 
organizational structure.  
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10. New market entrants’ overview 
In the Fortune 50 companies in healthcare industry, 14 are traditional healthcare companies 
and 24 are new entrants. Among these new entrants, 5 are technology companies and 3 are 
telecommunication companies. Among all 50, 24 has lately formed healthcare partnerships 
within care delivery (Statista, 2016). For example, Sanofi Canada together with 
telecommunication company Telus launched private self-management and health monitoring 
web-based platform (Telus Corporation, 2012) and 3M partnered Cerner Corporation, the 
EHR vendor (Heath, 2016). Moreover, SK Telecom company specialized in wireless 
communication from South Korea, formed a joint venture with Vista, company managing 
clinics in China (Sung-won, 2014). In 2013 Telefonica Group from Spain acquired Brazilian 
Axismed - chronic care management company (Sahota, 2013). In the mHealth market exist 
already 45.000 app publishers and more than half of them entered the market after 2013 
(Research2Guidance, 2015). Aslo lately venture capital investments changed direction from 
life sciences to startups that tackle the topics of mHealth, EMR systems and health 
management (PwC, 2014). New entrants in healthcare industry include completely new 
entities as well as companies emerging from other sectors. For example, Samsung and Apple 
started to issue patents and to produce smartphone-embedded devices for health monitoring 
such as Align Blood Glucose Monitor (iHealth, 2014). Calico is another healthcare new 
entrant. The company launched by Google aims on ageing population and related illnesses 
(Google Press, 2013). Chunyu mentioned before, the biggest doctor consultation platform in 
China already gains 80 million of Chinese patients and 40 thousand doctors (Siyang, 2015). 
These entrants appear on the health market with strong competitive advantages: many of them 
have strong relations with loads of clients and huge databases including information about 
Table 7 Examples of the new entrants on the eHealth market 
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them. For example, Walgreen’s Balance Rewards program, the loyalty program of U.S. 
pharmacy chain, has already gained data of over 81 million members (Walgreens, 2016) 
medications. (Delogne, 2015).  
Conclusions 
The research of the healthcare market news indicated that there can be clearly seen a big trend 
to invest in eHealth technologies. The citied examples confirm that the market is changing 
and new entrants try to win their share in a profit pool. Given this data, the hypothesis that 
mHealth creates new market players cannot be rejected. 
10. Summary of the findings 
Table 8 presents the summary of the findings. The research regarding eHealth performance 
illustrated the peculiarity of healthcare business. Although the technology initially 
demonstrated lower performance it could not enter the market unless the formal regulatory 
conditions weren’t fulfilled. eHealth represents comparable or improved performance to 
paper-based healthcare delivery. Therefore, the first hypothesis was rejected. Studies 
regarding leading customer’s attitude to technology pointed out many barriers to 
commercialize eHealth, such as privacy issues and required initial investment. However, the 
Table 8 Summary of findings 
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same studies indicated that majority of leading customers is supportive and enthusiastic 
towards eHealth. Therefore, this hypothesis can also be rejected.  The hypothesis about lower 
cost opportunity was supported by over 70% of studies which implies it cannot be rejected. 
Moreover, the examples of low-end, new market disruption and new market players created 
by eHealth indicate that hypothesis 4a and 4b and 5 cannot be rejected.  
Table 9 presents the summary of findings with regard to every analyzed technology. Only 
Computerized Physician Order Entry and Research Data Collection System fulfilled 3 out of 5 
conditions of disruptive theory. All research may indicate that eHealth is not a disruptive 
innovation in the theoretical understanding of the definition. 
11. Discussion 
In this paper, the disruptiveness of eHealth was elaborated in the context of its performance, 
end-user perception, costs and market changes that it has already caused. Understanding of 
the nature of a products disruptiveness might be of a central importance in a proccess of 
commercialization. Thus, the conclusions of this work might be a support for a strategic 
decision making for many stakeholders of the healthcare industry. Such examples are: 
entrepreneurs and investors considering entering the eHealth market, incumbents in the 
industry, and regulatory officials.  
The study indicated that eHealth, in general, is not a disruptive innovation in a tradditional 
understanding of a theory because it does not fulfill all the listed conditions. The conditions 
that were not fulfilled are: inferior initial performance and negative perception of the 
Table 9 Summary of findings with regard to the analyzed technologies 
26 
 
technology by incumbents’ leading customers. Three out of seven technologies did also not 
cause low-end nor the new market disruption.  
Limitations of the study 
Firstly, this research is limited by the scope of the literature. The articles were searched within 
only two databases which can imply that the findings may not be representative for all 
eHealth literature.  Moreover, articles from very specialized fields that did not include any 
variation of the general search queries, might have been omitted.  Furthermore, not published 
articles, non-english publications and “grey literature” have not been assessed. Besides, some 
of the analyzed studies are burdened with their own limitations such as: small sample size, 
short follow-up or no randomization. Another limitation is that despite rapid growth of 
available eHealth literature, this area still have not reach the maturity level. Therefore, is is 
difficult to synthetize the findings from divergent study designs, purposes and health areas.  
For example, general studies about eHealth or ICT within healthcare did not always include 
the range of the studied technologies. Another limitation is that in this work patient outcomes 
were classified as having positive or negative outcome with no regard to their importance – if 
it was a reduced mortality or an increased health management knowledge the outcome was 
categorized as positive.  
Directions for a future research 
The premise of this study was limited to the traditional disruptive innovation framework 
proposed by Christensen in 1995. However, taking under consideration the peculiarity of the 
healthcare industry, the specifics of disruptive innovation within this industry would be 
interesting to explore. Moreover, this research could be expanded to check mentioned 
specifics of healthcare areas like: dermatology, psychiatry, radiology etc. Furthermore, there 
are many innovations from various industries that are called disruptive in a common language 
27 
 
without datailed analysis, such as: autonomous vehicles, 5G infrastructure, Airbnb or Netflix. 
It might be reasonable to ask similar questions regarding those innovations. 
Acronym List:  
mHealth – mobile health 
EHR – Electronic Health Records 
CPOE – Computerized Physician Order Entry 
CDSS – Clinical Decision Support System 
RDCS – Research Data Collection System 
ICT – Information and Communication Technologies 
WHO – World Health Organization 
DALY – Disability Adjusted Life-Years 
QALY- Quality-Adjusted Life Year 
ROI – Return on Investment 
PMPY – Per Member Per Year 
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